Pulmuone Corporate (KRX:017810)
12,270
+190 (1.57%)
Apr 29, 2026, 3:30 PM KST
Pulmuone Corporate Revenue
In the year 2025, Pulmuone Corporate had annual revenue of 3.38T KRW with 5.18% growth. Pulmuone Corporate had revenue of 859.19B in the quarter ending December 31, 2025, with 5.07% growth.
Revenue
3,380.19B
Revenue Growth
+5.18%
P/S Ratio
0.13
Revenue / Employee
6.65B
Employees
508
Market Cap
445.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3,380.19B | 166.49B | 5.18% |
| Dec 31, 2024 | 3,213.70B | 220.23B | 7.36% |
| Dec 31, 2023 | 2,993.47B | 155.16B | 5.47% |
| Dec 31, 2022 | 2,838.30B | 319.41B | 12.68% |
| Dec 31, 2021 | 2,518.90B | 207.70B | 8.99% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nongshim Holdings | 858.82B |
| Samyang | 2,562.50B |
| Samlip | 3,370.48B |
| Namyang Dairy Products | 914.15B |
| Daesang Holdings | 5,628.80B |
| EASY HOLDINGS | 3,388.90B |
| Binggrae | 1,489.59B |
| Kwang Dong Pharmaceutical | 1,659.51B |